SPAKINECT CLINICAL GLOSSARY
Clinical Terms ❘ Terms within our Good Faith Exam
Good Faith Exam: A Good Faith Exam (GFE) is a required patient encounter that must occur before a patient receives any elective treatment(s). During the GFE, a licensed medical provider assesses the patient’s current condition, reviews their medical history, and determines whether they are an appropriate candidate for the requested treatment(s). The goal of the GFE is to establish a diagnosis and develop a safe and appropriate treatment plan. Each treatment evaluated during this encounter will result in one of four outcomes: approval, approval with precautionary warning, conditional approval, or deferral.
Treatment Plan: This section outlines the GFE outcome and provides a structured plan for the requested treatment(s) based on the patient's medical history. The treatment plan guides clinical care to ensure treatments are delivered safely, effectively, and in compliance.
Approval: An approval indicates that, based on the information available at the time of review, no contraindications have been identified. The treating provider is responsible for proceeding in accordance with established Standard Operating Procedures (SOPs) and individualized patient protocols.
Conditional Approval A conditional approval indicates that the patient may be medically cleared once specific conditions or instructions have been completed by the patient or clinical staff, such as completing a laser test spot or discontinuing a photosensitizing medication prior to treatment. All conditions must be clearly communicated and documented in the GFE form. The treating provider is responsible for proceeding in accordance with established Standard Operating Procedures (SOPs) and individualized patient protocols.
Deferral: A deferral indicates that the patient does not meet criteria for treatment authorization due to Spakinect policy, known product contraindications, or pre-existing medical conditions that increase the risk of adverse reactions. In cases of deferral, a medical clearance should be determined by the clinic’s MD or Medical Director.
Precautions: Specific warnings, risks, or modifications that must be taken with an otherwise approved treatment. When precautions are identified, the patient may move forward with treatment provided that recommended safeguards are followed. The treating provider is responsible for proceeding in accordance with established Standard Operating Procedures (SOPs) and individualized patient protocols.
Clinical Consideration: Treatment-specific guidance identified in relation to an approved treatment that informs how care should be safely and appropriately delivered or things that may be excluded from the GFE approval. This includes safety protocols, device requirements, or off-label considerations. Clinical considerations do not alter the formal GFE approval status but provide essential guidance for risk mitigation and treatment execution.
Telehealth Provider Notes: Patient‑specific instructions, guidance, and clinical rationale issued by the telehealth medical practitioner during the GFE are documented in this section of the completed GFE form.
Treatments ❘ Terms within our treatment database
Ablative Lasers: This is a type of laser that creates a wound on the epidermis of the skin and simultaneously heats the underlying skin (dermis), which stimulates the growth of new collagen fibers. As the epidermis heals and regrows, the treated area appears more firm with fewer wrinkles. Some common types of ablative laser treatments include the (CO2) laser, the erbium laser and combination systems. Ablative lasers carry a higher risk of permanent scarring than less invasive non ablative lasers.
Non-Ablative Lasers:This is a type of laser that stimulates collagen growth, which over time helps improve skin tone and texture, without causing any surface wounds to the epidermis of the skin. This approach can be done with various types of lasers as well as intense pulsed light (IPL) devices. Non-ablative lasers are less invasive and require less recovery time than ablative lasers.
Ablative/Non-Ablative Hybrid Laser: Hybrid laser systems can sequentially deliver two wavelengths: non-ablative and ablative wavelengths. This combined approach is designed to stimulate collagen remodeling while balancing efficacy with reduced recovery time compared to fully ablative treatments.
Hyaluronic Acid (HA) Fillers: Viscous, gel-like substances that are placed beneath the skin to help restore volume loss, create a fuller/smoother appearance, and soften lines.
Examples of HA Fillers included in the treatment plan: Belotero balance & Belotero balance +, Juvederm (Voluma XC, Vollure XC, XC, Ultra XC, Ultra Plus XC, Volbella XC, Volux XC, & Skinvive), Restylane (Kysse, Silk, Lyft, Refyne, & Defyne), Revanese (Versa, Versa +. & Lips+), The RHA Collection (RHA 2, RHA 3, & RHA 4), Evolysse (Smooth & Form)
This list is maintained on an ongoing basis and is subject to change.
Biostimulating Fillers: Injectable treatments designed to stimulate the body’s natural collagen production over time while providing structural support and gradual volume restoration. Unlike traditional hyaluronic acid fillers, biostimulating fillers promote a regenerative response that improves skin firmness, texture, and contour progressively.
Examples of Biostimulating Fillers included in the treatment plan: Bellafill, Radiesse, and Sculptra.
This list is maintained on an ongoing basis and is subject to change.
Neuromodulators (Injectable): Work by temporarily relaxing targeted facial muscles to reduce the appearance of dynamic wrinkles and lines. They are commonly used in areas such as the forehead, between the eyebrows, and around the eyes.
Examples of Neuromodulators included in the treatment plan: Botox, Daxxify, Dysport, Jeuveau, Letybo, Xeomin
This list is maintained on an ongoing basis and is subject to change.
Medical-Grade Skincare Products: Medical-grade skincare products are specially formulated topical treatments designed to improve skin health, texture, and appearance. They often contain higher concentrations of active ingredients than over-the-counter products and are used to complement in-office treatments.
Radiofrequency Ablative: A treatment modality that delivers radiofrequency energy to intentionally ablate (remove or vaporize) targeted tissue layers, creating controlled thermal injury to stimulate collagen remodeling and tissue renewal. Ablative RF treatments typically involve downtime and require specific post-procedure care.
Radiofrequency Non-Ablative: A treatment modality that delivers radiofrequency energy to heat underlying tissue without ablating or removing the skin surface. Non-ablative RF treatments promote collagen stimulation and skin tightening while preserving the epidermis and generally involve minimal downtime.
Peptide Therapy: Short chains of amino acids intended to support physiological functions such as cellular signaling, tissue repair, metabolic regulation, or aesthetic goals. Peptide therapy may be delivered via various routes. Clients should establish protocols through their medical director for Peptide Therapy. In addition, a patient specific order should clearly define all screening, dosing, and monitoring requirements. Find more information on our Peptide Therapy Clearance here.
Intravenous (IV) Vitamin & Supplement Infusion: A method of treatment delivery in which fluids, vitamins, medications, or other therapeutic substances are administered directly into the bloodstream through a vein. IV infusion protocols are established by the clinic, and all clinical staff must follow the clinic’s approved IV therapy protocols and patient-specific orders. IV infusion ingredients, dosages, and administration parameters may vary based on individual patient orders and the protocols set forth and approved by the clinic’s Medical Director. A complete ingredient list is available here.
All of our GFE outcomes for IV infusions are issued as conditional approvals based on blood pressure (BP) assessment. Treatment may proceed only after BP has been assessed onsite using a calibrated sphygmomanometer and reviewed prior to initiation. Spakinect recommends that BP be less than 160/90 mmHg and greater than 90/50 mmHg prior to receiving treatment.